ALFA Filings
Every announcement, straight from the exchange
Every corporate announcement our alert engine sent, newest first: orders, results, earnings calls, fund raises, board meetings and more.
Announcement type
Time
152,660 announcements with these filters
Bajaj Auto Ltd reported total sales of 5,13,792 units for April 2026, a 40% increase over April 2025. Two-wheeler sales rose 38% to 4,39,953 units, while commercial vehicle sales surged 54% to 73,839 units. Combined exports showed strong growth of 83% year-on-year.
Adani Ports and Special Economic Zone Ltd (APSEZ) handled 43.1 MMT of cargo in April 2026, marking a 15% YoY growth. Growth was driven by container and dry cargo volumes, both increasing 17%. Logistics rail volume stood at 48,490 TEUs, a 16% YoY decline. The performance indicates strong momentum in core port operations.
OneSource Specialty Pharma's partner, Orbicular, received Health Canada approval for a generic version of Ozempic (semaglutide). This marks the second generic semaglutide approval in Canada, the world's second-largest market for the drug. OneSource will support commercial supply from its FDA-approved Bengaluru facility, strengthening its global CDMO position in complex injectables.
Swaraj Suiting Limited allotted equity shares via a preferential issue at a price of ₹236 per share. The allotment follows board approval from November 2025 and results in a total fund raise of approximately ₹0.78 Crore from two investors.
Swaraj Suiting Limited allotted 33,000 equity shares at ₹236 per share on a preferential basis to two investors. This ₹0.78 Crore capital raise increases the company's paid-up share capital to ₹26.42 Crore.
SPR Auto Technologies Limited has scheduled a Board Meeting for May 11, 2026. The board will consider audited financial results for the quarter and year ended March 31, 2026, and recommend a final dividend for FY 2025-26. The trading window remains closed until 48 hours after the results are announced.
Rajeswari Infrastructure Limited reported audited standalone financial results for the year ended March 31, 2026. The company posted a net loss of ₹13.05 Lakhs for the full year. The Monitoring Committee, overseeing operations following the NCLT-approved resolution plan, adopted the results on a going concern basis. The statutory auditor issued a disclaimer of opinion.
Rajeswari Infrastructure Ltd reported standalone results for Q3 FY2026, posting a net loss of ₹3.65 Lakhs on total income of ₹0.03 Lakhs. The company is currently managed by a Monitoring Committee following the approval of a resolution plan under CIRP. Financial statements were prepared on a going concern basis despite auditor's disclaimer of opinion.
Mitsu Chem Plast reported Q4 FY26 revenue of ₹8647.46 Lakhs and EBITDA of ₹1422.74 Lakhs. Strategy focuses on healthcare furniture and packaging under 'Furnastra' brand.
Rajeswari Infrastructure Ltd reported unaudited financial results for the quarter ended September 30, 2025, with a net loss of ₹3.05 Lakhs. The company is under the Corporate Insolvency Resolution Process (CIRP). The statutory auditor issued a disclaimer of opinion due to insufficient audit evidence regarding opening balances, inventories, and liabilities under the resolution plan.
Rajeswari Infrastructure Ltd reported standalone financial results for the quarter ended June 30, 2025. The company remains under a Monitoring Committee following its Corporate Insolvency Resolution Process (CIRP). The statutory auditor issued a Disclaimer of Opinion citing insufficient evidence regarding opening balances, going concern assumptions, and asset valuations.
Rajeswari Infrastructure Ltd's Monitoring Committee approved audited standalone financial results for FY 2024-25. The company recently concluded its Corporate Insolvency Resolution Process (CIRP) with the NCLT approving a resolution plan. Auditors issued a Disclaimer of Opinion citing lack of sufficient audit evidence for several balance sheet items and ongoing restructuring adjustments.
Rajeswari Infrastructure Ltd reported unaudited financial results for the quarter ended December 31, 2024. The Monitoring Committee approved the results, noting the company is undergoing a resolution plan under CIRP. The statutory auditor issued a disclaimer of opinion due to insufficient audit evidence regarding opening balances and various asset/liability valuations.
Rajeswari Infrastructure Ltd reported standalone financial results for Q2 FY25, showing total income of ₹0.01 Crore and a net loss of ₹0.03 Crore. The company remains under a Monitoring Committee following its Corporate Insolvency Resolution Process. Auditors issued a disclaimer of opinion due to insufficient evidence regarding various assets, liabilities, and going concern assumptions.
Rajeswari Infrastructure Ltd reported net profit of ₹0 Cr for Q1 FY25.
Rajeswari Infrastructure Ltd reported its Q1 FY25 (ended June 30, 2024) standalone results with a total income of ₹0.0005 Crore (₹0.05 Lakhs). The company remains under the Corporate Insolvency Resolution Process (CIRP) framework, with a Monitoring Committee overseeing operations following the NCLT's approval of a resolution plan in January 2026.
Mitsu Chem Plast Ltd issued a corrigendum to its Q4 and FY26 earnings release to correct a unit error from 'Crores' to 'Lakhs'. The updated results show FY26 Net Profit of ₹15.62 Crore on Total Income of ₹350.85 Crore.
Xchanging Solutions Limited announced the approval of Mrs. Padmaja Priyadarshini as a Non-Executive and Independent Director via postal ballot. The resolution was passed with a 99.91% majority through remote e-voting concluded on May 2, 2026. This appointment strengthens the company's board governance and ensures compliance with independent director requirements.
Epigral achieved record Q4 revenue driven by 15% volume growth, though full-year profits were dragged by earlier operational headwinds and suppressed pricing.
Epigral delivered record quarterly revenue of ₹736cr, driven by a 15% QoQ volume surge and plant stabilization after major maintenance, despite geopolitical volatility.
SMC Global reported FY26 consolidated revenue of ₹1,876.9 Cr (+5.7% YoY) but PAT declined 29.7% to ₹103.2 Cr. Q4 showed strong recovery with PAT up 424% YoY on normalized market activity.
SMC Global Securities reported Q4-FY26 revenue of INR 516.9 Cr (+22.6% YoY) and PAT of INR 21.5 Cr (+424.4% YoY). Focus remains on technology-led growth and insurance broking diversification.
Sodhani Capital Limited announced the conclusion of its postal ballot process on May 3, 2026. Shareholders approved special resolutions for altering the company's Object Clause and increasing limits for investments, loans, and guarantees under Section 186. The e-voting was scrutinized by Mr. Rounak Bansal, confirming compliance with SEBI and MCA regulations.
GRM Overseas Limited announced the voting results of its Extra-Ordinary General Meeting held on May 02, 2026. Shareholders approved an alteration to the company's Object Clause and the re-appointment of Mrs. Nidhi as an Independent Director with requisite majority.
Suzlon Energy Limited announced the cessation of Mr. Gautam Doshi as a Non-Executive Independent Director effective May 4, 2026. The departure follows the completion of his scheduled tenure on the board.
Mr. Gautam Doshi will cease to be an Independent Director of Suzlon Energy Limited on May 4, 2026, following the completion of his second tenure. He will also step down from his roles in the Audit, Risk Management, and CSR & ESG Committees.
Trescon Ltd has scheduled a Board of Directors meeting on Tuesday, May 12, 2026. The board will primarily consider and approve the audited financial results for the quarter and financial year ended March 31, 2026.
RNIT AI Solutions reported strong FY26 performance with 60% revenue growth, focused on AI-led e-Governance, facial recognition, and conversational AI (NIA).
Arvee Laboratories (India) Limited has scheduled a Board Meeting for May 18, 2026, to approve the audited standalone financial results for the year ended March 2026. The company also confirmed that the trading window for designated persons has been closed since April 1, 2026.
Arvee Laboratories (India) Limited has scheduled a board meeting on May 18, 2026, to consider and approve the audited standalone financial results for the year ended March 31, 2026. The trading window for designated persons remains closed until May 20, 2026.